Successful Implant of a Subcutaneous ICD System in a Patient with an Ipsilateral Epicardial Pacemaker  by Hong, Paul S.G. et al.
62
Case Report
Successful  Implant  of  a  Subcutaneous  ICD  System  in  a 
Patient with an Ipsilateral Epicardial Pacemaker
Paul SG Hong MRCP1, Peter Callinan B.App.Sci2, Guy Amit MD, MPH1, Jeff S Healey MD, 
FHRS1  
1Arrhythmia  Division,  Hamilton  Health  Sciences-McMaster  University,  Hamilton,  ON, 
Canada
2Boston  Scientific  Canada,  Mississauga,  ON,  Canada                                 
Address  for  Correspondence:  Dr  Jeff  S.  Healey,  Population  Health  Research  Institute, 
McMaster University, Room C3-121, David Braley CVSRI, 237 Barton St East, Hamilton, 
Ontario L8L 2X2,  Canada.  Email:  jeff.healey@phri.ca                                  
Conflict  of  Interest  Disclosures: Dr.  Hong  is  partially  funded  by  the  Dowager  Countess 
Eleanor Peel Trust (Peel and Rothwell Jackson Travelling Fellowship), United Kingdom. P 
Callinan is employed by Boston Scientific.  Dr. Healey has a personnel award from the Heart 
and Stroke  Foundation,  Ontario  Provincial  office  (MC7450).                            
Key words: Sudden cardiac death, arrhythmia, implantable cardioverter-defibrillator               
Case
A 25  year  old  female  with  a  history  of  intravenous  drug  abuse  developed  Staph  Aureus 
endocarditis and required mitral and tricuspid valve replacement with tissue bioprostheses. Her 
recovery was complicated by new, severe aortic regurgitation requiring a bioprosthetic aortic 
valve replacement several days later. She was noted to be in third degree AV block during the 
second operation and a permanent bipolar epicardial pacing lead was placed intra-operatively 
on  the  right  ventricle.  Subsequently  this  lead  was  tunneled  subcutaneously  from  the 
epigastrium to the left pre-pectoral position and attached to a single-chamber pacemaker pulse 
generator.  
Whilst convalescing on the ward the patient suffered two cardiac arrests due to polymorphic 
VT despite  consistent  pacing  at  50  bpm.  There  was  no  evidence  of  QT prolongation  or 
coronary artery disease and therefore overdrive pacing was not originally indicated. Moreover, 
her  left  ventricular  systolic  function was also within normal  limits.                      
However; the treating team felt that given the patient's valve disease and two cardiac surgical 
procedures, that there had to be a substrate for recurrent arrhythmia, presumably small areas of 
myocardial scar. In addition to increasing the lower pacing rate to 90 bpm, the decision was 
taken to implant a subcutaneous ICD (S-ICD system, Boston Scientific/Cameron Health). An 
S-ICD was selected due to the risk of further infection with a transvenous ICD; however we 
were concerned about possible device-device interaction. We had also considered connecting 
the epicardial pacing lead to a standard ICD and adding a subcutaneous array but we felt the S-
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ICD to be the best option.                                                                               
Prior to the procedure, pre-implant screening was undertaken to ensure adequate sensing by 
the S-ICD system of the subcutaneous ECG signals. In this patient, both her paced rhythm and 
her intrinsic junctional escape rhythm were screened to ensure that neither posed an issue with 
T-wave  over-sensing.                                        
 
Implantation  of  the  S-ICD  system  was  undertaken  using  standard  techniques.  Our  main 
concern  was  ensuring  there  was  no  potential  interaction  between  the  proximal  sensing 
electrode  of  the  S-ICD  lead  with  the  main  loops  of  the  epicardial  pacemaker  lead 
subcutaneously adjacent  to the xiphisternum. Pre-procedure fluoroscopy was used to guide 
generator placement and the lead tunneling process.  During the procedure, careful palpation 
and  dissection  ensured  that  the  ICD  lead  did  not  come  into  contact  with  the  epicardial 
pacemaker lead. We were able to confirm fluoroscopically that the proximal sensing electrode 
of the ICD was placed beyond the epicardial lead loops. The 8cm defibrillation coil was then 
positioned in the usual manner.  There were no acute complications from the implant. Lead 
parameters on both the ICD and the pacemaker were satisfactory post-implant. (Figures 1 and 
2).
Figure 1: PA x-ray view post implant of the S-ICD system. The arrows denote the two poles of the bifurcated  
bipolar epicardial pacing lead. The asterisk marks the position of the proximal sensing electrode of the S-ICD 
system.
Additionally no interference was detected on the sensing circuit of either device. Defibrillation 
threshold  testing  was  conducted  post  procedure,  but  no  ventricular  arrhythmias  were 
inducible.  However, three weeks post-implant, she presented with polymorphic VT which was 
successfully  detected  and defibrillated  by the S-ICD system (Figure 3).  She remains  well 
currently although she continues to be followed up closely.  Analysis  of both devices at 6 
weeks post procedure revealed no issues.  
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Figure 2: Lateral x-ray view, with the arrow denoting the S-ICD lead coursing superiorly over the loops of the 
epicardial pacing lead.  The asterisk marks the position of the proximal sensing electrode of the S-ICD system. 
Figure 3: A run of polymorphic VT caught on ECG telemetry culminating in an 80 J shock from the S-ICD 
system. The pacemaker can be observed pacing through the VT in noise-reversion mode.                          
Registry data suggest that the S-ICD is comparable to standard ICDs in terms of performance 
and  inappropriate  shock rates  [1].  This  is  the  first  reported  case  of  the  combination  of  a 
permanent  pacemaker  utilising  an  epicardial  lead  with  an  ipsilateral  subcutaneous  ICD 
implant.  Judicious pre-planning of the surgery as well  as careful  dissection and tunnelling 
within the surgical field ensured no damage or manipulation of the existing epicardial lead and 
also optimal placement of the subcutaneous ICD system. In our particular experience, although 
fluoroscopy is  usually  not  required  for  an  S-ICD implant,  it  was  vital  in  this  case in  the 
planning of the final lead positioning as well as documenting, in real-time, the course of the 
epicardial pacemaker lead. In addition, it  was important that pre-implant screening ensured 
that the S-ICD system did not experience T-wave over-sensing with both the patient's paced 
and  intrinsic  rhythms.                                                
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